Cathay Biotech Investor
Cathay is a global technology leader in synthetic biology and the use of bio-processes to produce new materials on an industrial scale.
Founded Date:
1997-01-01
Last Funding Type:
Series B
Headquarters:
Shanghai, Shanghai, China
Investors Number:
1
Estimated Revenue:
$100M to $500M
Last Funding Date:
2019-06-14
Funding Status:
IPO
Total Funding:
69000000.0